Northeast Pharmaceutical Group Co., Ltd. (SHE:000597)
China flag China · Delayed Price · Currency is CNY
5.32
-0.11 (-2.03%)
Apr 9, 2026, 3:04 PM CST

SHE:000597 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Cash & Equivalents
3,6024,4685,6513,8452,550
Trading Asset Securities
0.35----
Cash & Short-Term Investments
3,6024,4685,6513,8452,550
Cash Growth
-19.39%-20.93%46.98%50.76%72.18%
Accounts Receivable
2,4232,4942,4042,5392,376
Other Receivables
186.39192.51191.25195.93392.21
Receivables
2,6102,6872,5962,7352,768
Inventory
1,1821,3241,3641,2201,247
Prepaid Expenses
-0.631.172.8616.64
Other Current Assets
138.82166.73171.05127.39216.56
Total Current Assets
7,5328,6469,7837,9316,799
Property, Plant & Equipment
3,6304,0644,4774,8525,226
Long-Term Investments
4.736.13---
Goodwill
153.4154.4526.1226.1226.12
Other Intangible Assets
661.23687.83681.77706.96651.76
Long-Term Deferred Tax Assets
137.64131.38128.07109.29102.09
Long-Term Deferred Charges
762.72742.05143.47122.36302.5
Other Long-Term Assets
6.6513.9734.4762.6671.34
Total Assets
12,88914,44615,27413,81013,180
Accounts Payable
2,8624,8415,7784,3203,696
Accrued Expenses
36.18853.78744.07701.69561.28
Short-Term Debt
1,8921,5421,2901,8822,050
Current Portion of Long-Term Debt
80.59-68842200
Current Portion of Leases
-20.2323.5217.5820.21
Current Income Taxes Payable
57.7146.2255.58104.5828.27
Current Unearned Revenue
87.9104.81131.17192.72127.78
Other Current Liabilities
1,547849.18858.071,1621,515
Total Current Liabilities
6,5648,2579,5688,4238,199
Long-Term Debt
154.6-150238200
Long-Term Leases
19.8230.1431.2917.9417.97
Long-Term Unearned Revenue
126.2140.91157.12174.72194.05
Long-Term Deferred Tax Liabilities
93.7395.745.225.325.42
Other Long-Term Liabilities
261.56352.83202.8238273.2
Total Liabilities
7,2208,87710,1159,0978,889
Common Stock
1,4271,4291,4291,4341,348
Additional Paid-In Capital
2,5192,4902,4682,3752,146
Retained Earnings
1,5781,4611,194978.13646.81
Treasury Stock
-2.47-67.13-110.72-234.78-
Comprehensive Income & Other
7.848.978.417.172.65
Total Common Equity
5,5305,3224,9884,5594,144
Minority Interest
139.4248.03170.47153.95146.54
Shareholders' Equity
5,6695,5705,1594,7134,290
Total Liabilities & Equity
12,88914,44615,27413,81013,180
Total Debt
2,1471,5932,1832,1982,488
Net Cash (Debt)
1,4552,8763,4681,64762.17
Net Cash Growth
-49.39%-17.08%110.51%2549.68%-
Net Cash Per Share
1.012.032.421.180.04
Filing Date Shares Outstanding
1,4941,4291,4291,4341,348
Total Common Shares Outstanding
1,4941,4291,4291,4341,348
Working Capital
968.51389.56214.57-492.6-1,399
Book Value Per Share
3.703.723.493.183.07
Tangible Book Value
4,7154,4794,2803,8263,466
Tangible Book Value Per Share
3.163.133.002.672.57
Buildings
-3,1233,1013,0112,965
Machinery
-5,1775,0474,8084,606
Construction In Progress
-155.48198.87421.64678.41
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.